News
Bloomberg on MSN13h
MiRXES Says China Will Be An Important MarketMiRXES Co-Founder & CEO Lihan Zhou says the Chinese market is key, as it gives his company the scale to bring down cost. The Singapore-based biotechnology startup made its Hong Kong initial public ...
Congress has not been able to reauthorize environmental statutes for years, with some (most) needing significant attention. EPA relies on 1990 Clean Air Act amendments to sort out air pollution issues ...
Nine states in the Southeast showed growth in bioscience employment and establishments from 2019 to 2023, according to 2024 ...
Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...
Learn about the battle against antimicrobial resistance (AMR) in India, the development of new antibiotics, and the urgent ...
Explore the controversial implications of Roundup and glyphosate in American agriculture amid political and scientific ...
Learn more about whether BioCryst Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc. is a better investment based on ...
Syantra, Inc., has recently completed new patent filings that expand previous work in cancer molecular diagnostics to encompass new drug targets and therapeutics.
Advancements and Challenges in Biotechnology and Biocontrol Strategies to Solve Agri-food Infections
Despite advancements in microbial safety strategies, agri-food systems remain vulnerable to microbial infections, posing significant threats to food safety, ...
The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from ...
The Supreme Court (SC) reminded employers that once their job offers are accepted by the workers, an employer-employee ...
The istaroxime data will be presented by Jan Biegus MD, Institute of Heart Diseases, Wroclaw Medical University, Wrocław, Poland. The presentation is entitled, "Safety and Efficacy of up to 60 Hours ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results